5 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 5, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Gastric Neoplasm: new trials by email Literature Review of Gastric Neoplasm trials Research Report on Gastric Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression Fruquintinib Combined with Sintilimab and Stereotactic Body Radiation Therapy - Gastric Neoplasm | Phase 2 / Phase 3 | Not yet recruiting | Queling Liu | 30 | 2025-06-01 | 2025-05-16 |
| Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer Docetaxel, Oxaliplatin, Leucovorin - Gastric Cancer, Stomach Cancer | Phase 2 / Phase 3 | Recruiting | Ukrainian Society of Clinical Oncology | 150 | 2025-03-25 | 2025-05-06 |
| RCT of Gastric ESD With or Without Epineprhine Added Solution Endoscopic submucosal dissection, Epinephrine - Gastric Neoplasm, Early Gastric Cancer | Phase 3 | Completed | Chinese University of Hong Kong | 800 | 2020-01-10 | 2025-05-04 |
| A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer Gastrectomy with more than D2 dissection, Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy - Gastric Neoplasm | Phase 3 | Completed | Haruhiko Fukuda | 316 | 2005-11-01 | 2016-09-22 |
| GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110 Surgery: Splenectomy, Surgery: Spleen-preservation - Gastric Neoplasm | Phase 3 | Completed | Haruhiko Fukuda | 500 | 2002-06-01 | 2016-09-22 |
| Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502) Surgery: abdominal and transhiatal approach, Surgery: left thoraco-abdominal approach - Gastric Neoplasm | Phase 3 | Terminated | Japan Clinical Oncology Group | 167 | 1995-07-01 | 2009-02-03 |
| A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer Surgery: D2 dissection, Surgery: D2+paraaortic dissection - Gastric Neoplasm | Phase 3 | Completed | Japan Clinical Oncology Group | 520 | 1995-07-01 | 2016-09-22 |
| Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2) Gastrectomy with D2 or greater lymph node dissection, Gastrectomy+ chemotherapy - Gastric Neoplasm | Phase 3 | Completed | Japan Clinical Oncology Group | 280 | 1993-01-01 | 2016-09-22 |
Stomach Neoplasms (8) · Gastrointestinal Neoplasms (1) · Neoplasms (1)
Digestive System Diseases (8) · Digestive System Neoplasms (8) · Gastrointestinal Diseases (8) · Neoplasms by Site (8) · Stomach Diseases (8) · Gastrointestinal Neoplasms (7) · Neoplasms (7)
Gastrectomy (2) · Docetaxel (1) · Endoscopic Mucosal Resection (1) · Epinephrine (1) · Fluorouracil (1) · Leucovorin (1) · Oxaliplatin (1) · Radiosurgery (1) · sintilimab (1)
Japan Clinical Oncology Group (3) · Haruhiko Fukuda (2) · Chinese University of Hong Kong (1) · Queling Liu (1) · Ukrainian Society of Clinical Oncology (1)
Japan (6) · Hong Kong (1) · Lithuania (1) · Singapore (1) · South Korea (1) · Ukraine (1)
Mitsuru Sasako, MD (2) · Mitsuru Sasako, MD, PhD (2) · Hiroshi Furukawa, MD, PhD (1) · Hon Chi Yip, MBChB, FRCSEd (1) · Mykyta Pepenin, MD (1)
PMID 21104822, PMID 16887481, PMID 18669424, PMID 21336855, PMID 25605628, PMID 41620139